Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Jenner

Showing results (71-80 of 177) with videos related to

Pageof 18
Sort By:
Brain Research|November 10, 2004
Role of inducible nitric oxide synthase in N-methyl-d-aspartic acid-induced strio-nigral degenerationMahmoud M Iravani, Lin Liu, Sarah Rose, et al.
Journal of Neuroscience Research|September 1, 2005
Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insultsDong-Hoon Hyun, Moonhee Lee, Barry Halliwell, et al.
Nature Reviews. Neuroscience|June 9, 2017
Non-motor features of Parkinson diseaseAnthony H V Schapira, K Ray Chaudhuri, Peter Jenner
Parkinsonism & Related Disorders|October 14, 2015
Non motor subtypes and Parkinson's diseaseAnna Sauerbier, Peter Jenner, Antoniya Todorova, et al.
Nature Reviews. Neuroscience|July 20, 2017
Non-motor features of Parkinson diseaseAnthony H V Schapira, K Ray Chaudhuri, Peter Jenner
Journal of Neural Transmission (Vienna, Austria : 1996)|May 1, 2014
Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell lossMahmoud M Iravani, Mona Sadeghian, Sarah Rose, et al.
Clinical Therapeutics|January 30, 2010
Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studiesPeter Jenner, Michael Könen-Bergmann, Cornelia Schepers, et al.
Brain Research|February 24, 2010
A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsySalma Bukhatwa, Bai-Yun Zeng, Sarah Rose, et al.
Expert Opinion on Drug Safety|October 18, 2019
Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An updateValentina Leta, Peter Jenner, K Ray Chaudhuri, et al.
Journal of Neurochemistry|June 18, 2002
5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neuronsJeremy P E Spencer, Matthew Whiteman, Peter Jenner, et al.
Pageof 18

Showing results (71-80 of 177) with videos related to

Sort By:
Pageof 18
Brain Research|November 10, 2004
Role of inducible nitric oxide synthase in N-methyl-d-aspartic acid-induced strio-nigral degenerationMahmoud M Iravani, Lin Liu, Sarah Rose, et al.
Journal of Neuroscience Research|September 1, 2005
Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insultsDong-Hoon Hyun, Moonhee Lee, Barry Halliwell, et al.
Nature Reviews. Neuroscience|June 9, 2017
Non-motor features of Parkinson diseaseAnthony H V Schapira, K Ray Chaudhuri, Peter Jenner
Parkinsonism & Related Disorders|October 14, 2015
Non motor subtypes and Parkinson's diseaseAnna Sauerbier, Peter Jenner, Antoniya Todorova, et al.
Nature Reviews. Neuroscience|July 20, 2017
Non-motor features of Parkinson diseaseAnthony H V Schapira, K Ray Chaudhuri, Peter Jenner
Journal of Neural Transmission (Vienna, Austria : 1996)|May 1, 2014
Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell lossMahmoud M Iravani, Mona Sadeghian, Sarah Rose, et al.
Clinical Therapeutics|January 30, 2010
Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studiesPeter Jenner, Michael Könen-Bergmann, Cornelia Schepers, et al.
Brain Research|February 24, 2010
A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsySalma Bukhatwa, Bai-Yun Zeng, Sarah Rose, et al.
Expert Opinion on Drug Safety|October 18, 2019
Can therapeutic strategies prevent and manage dyskinesia in Parkinson's disease? An updateValentina Leta, Peter Jenner, K Ray Chaudhuri, et al.
Journal of Neurochemistry|June 18, 2002
5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neuronsJeremy P E Spencer, Matthew Whiteman, Peter Jenner, et al.
Pageof 18